342 related articles for article (PubMed ID: 25811654)
21. Influenza vaccine immunology.
Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
[TBL] [Abstract][Full Text] [Related]
22. [Immunity against influenza virus infection].
Takada A
Nihon Rinsho; 2010 Sep; 68(9):1625-30. PubMed ID: 20845738
[TBL] [Abstract][Full Text] [Related]
23. The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.
Nienen M; Stervbo U; Mölder F; Kaliszczyk S; Kuchenbecker L; Gayova L; Schweiger B; Jürchott K; Hecht J; Neumann AU; Rahmann S; Westhoff T; Reinke P; Thiel A; Babel N
Front Immunol; 2019; 10():593. PubMed ID: 31019503
[TBL] [Abstract][Full Text] [Related]
24. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.
Nguyen HH; Moldoveanu Z; Novak MJ; van Ginkel FW; Ban E; Kiyono H; McGhee JR; Mestecky J
Virology; 1999 Feb; 254(1):50-60. PubMed ID: 9927573
[TBL] [Abstract][Full Text] [Related]
25. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
26. The coexistence or replacement of two subtypes of influenza.
Asaduzzaman SM; Ma J; van den Driessche P
Math Biosci; 2015 Dec; 270(Pt A):1-9. PubMed ID: 26453807
[TBL] [Abstract][Full Text] [Related]
27. Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
Hillaire ML; Osterhaus AD; Rimmelzwaan GF
J Biomed Biotechnol; 2011; 2011():939860. PubMed ID: 22007149
[TBL] [Abstract][Full Text] [Related]
28. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
Krammer F
Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
[TBL] [Abstract][Full Text] [Related]
29. Pandemic preparedness: toward a universal influenza vaccine.
Roose K; Fiers W; Saelens X
Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
[TBL] [Abstract][Full Text] [Related]
30. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
31. Vaccination against influenza: role and limitations in pandemic intervention plans.
Rebmann T; Zelicoff A
Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly.
Powers DC; Manning MC; Hanscome PJ; Pietrobon PJ
J Infect Dis; 1995 Oct; 172(4):1103-7. PubMed ID: 7561189
[TBL] [Abstract][Full Text] [Related]
33. T cell mediated immunity to influenza: mechanisms of viral control.
La Gruta NL; Turner SJ
Trends Immunol; 2014 Aug; 35(8):396-402. PubMed ID: 25043801
[TBL] [Abstract][Full Text] [Related]
34. Development of a universal CTL-based vaccine for influenza.
Cargnelutti DE; Sánchez MV; Mattion NM; Scodeller EA
Bioengineered; 2013; 4(6):374-8. PubMed ID: 23337287
[TBL] [Abstract][Full Text] [Related]
35. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
[TBL] [Abstract][Full Text] [Related]
36. Considerations for the rapid deployment of vaccines against H7N9 influenza.
Chua BY; Brown LE; Jackson DC
Expert Rev Vaccines; 2014 Nov; 13(11):1327-37. PubMed ID: 25017993
[TBL] [Abstract][Full Text] [Related]
37. Optimal control of vaccination dynamics during an influenza epidemic.
Jaberi-Douraki M; Moghadas SM
Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
[TBL] [Abstract][Full Text] [Related]
38. Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines.
Biswas A; Chakrabarti AK; Dutta S
Int Rev Immunol; 2020; 39(1):21-36. PubMed ID: 31707873
[TBL] [Abstract][Full Text] [Related]
39. [Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination].
Naĭkhin AN
Vopr Virusol; 2012; 57(3):4-9. PubMed ID: 22905419
[TBL] [Abstract][Full Text] [Related]
40. Vaccines for pandemic influenza.
Luke CJ; Subbarao K
Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
